International Journal of Clinical and Diagnostic Pathology

International Journal of Clinical and Diagnostic Pathology

Login    Signup
Printed Journal   |   Indexed Journal   |   Refereed Journal   |   Peer Reviewed Journal

International Journal of Clinical and Diagnostic Pathology

2022, Vol. 5 Issue 1, Part BPages: 72-76

The role of p63 Myoepithelial cell marker in papillary lesions of the breast

Durre Aden, Nishat Afroze, Zaheer Sufian, Asim Israr Khan, Taiba Khan and Meher Aziz
Viewed: 126  -  Downloaded: 78
ABSTRACT
Background: To diagnose various histological types of papillary lesions of the breast according to the newer WHO classification and to study the expression of myoepithelial cell marker p63 in various papillary lesions.
Material and Methods: The study was done on 21 patients with breast lesions between Jan 2015 to June 2016. Breast biopsies (incisional as well as excisional) were retrieved from the histopathology section of the department.
Result: P63 showed a nuclear positivity in myoepithelial cells. It was retained in the benign papillary lesions with some exceptions and was almost completely lost in malignant papillary neoplasms Conclusion: P63 can be used to observe the characteristic pattern of nuclear staining and delineate the myoepithelial layer wherever needed.
How to cite this article:
Durre Aden, Nishat Afroze, Zaheer Sufian, Asim Israr Khan, Taiba Khan and Meher Aziz. The role of p63 Myoepithelial cell marker in papillary lesions of the breast. International Journal of Clinical and Diagnostic Pathology. 2022; 5(1): 72-76. DOI: 10.33545/pathol.2022.v5.i1b.455
International Journal of Clinical and Diagnostic Pathology